NCT04143711 2026-03-18
Study of DF1001 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Phase 1/2 Completed
Dragonfly Therapeutics
Bristol-Myers Squibb
University of Kansas Medical Center
Bolt Biotherapeutics, Inc.
Seoul National University Hospital
National Cancer Institute (NCI)